DR. NICOLA LONGO MD
Prescription History 1275612749
Medical Genetics - Clinical Genetics (M.D.) in Los Angeles, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. NICOLA LONGO MD, an active Clinical Genetics (M.D.) specialist practicing in Los Angeles, CA. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 76 documented patient claims. Among these therapy options, the most frequently utilized medication is Nexviazyme, which accounts for 26 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| NexviazymeAvalglucosidase Alfa-Ngpt | 26 | $72,470.63 | ▲ More than typical |
About Nexviazyme: This medication is used by people with a certain inherited condition (Pompe disease) to reduce high levels of a certain substance (glycogen) that builds up in the blood. Show more ▾ Having high levels of glycogen in the blood may cause muscle weakness, heart problems, and breathing problems. Avalglucosidase alfa works by breaking down glycogen in the blood. In 2023, this provider wrote 26 Medicare prescriptions for Nexviazyme, about 1.6 times the volume of the typical California prescriber of this medication (16). Medicare paid an average of $72,470.63 per fill, versus $65,272.70 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2023 | |||
| Miglustat | 14 | $884.53▼ below CA avg | ≈ Typical |
About Miglustat: Miglustat is used for the long-term treatment of a certain rare genetic problem (Gaucher's disease). Show more ▾ It works by decreasing the amount of a certain natural fatty substance (glucosylceramide) that builds up due to this condition. This can help improve symptoms of Gaucher's disease, such as tiredness, pain in the joints/bones, and a swollen liver or spleen. In 2023, this provider wrote 14 Medicare prescriptions for Miglustat, about the same volume as the typical California prescriber of this medication (13). Medicare paid an average of $884.53 per fill, versus $1,903.28 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 14 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2023 | |||
| KuvanSapropterin Dihydrochloride | 13 | $19,345.38▼ below CA avg | ≈ Typical |
About Kuvan: This medication is used along with diet changes for long-term treatment of a certain inherited disorder (phenylketonuria-PKU). Show more ▾ It helps remove a certain chemical (phenylalanine) from the body. Too much phenylalanine in the body can cause brain damage. In 2023, this provider wrote 13 Medicare prescriptions for Kuvan, about the same volume as the typical California prescriber of this medication (12). Medicare paid an average of $19,345.38 per fill, versus $20,130.00 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| Carbamazepine | 12 | $108.02 | ▼ Less than typical |
About Carbamazepine: Carbamazepine is used to prevent and control seizures. Show more ▾ This medication is known as an anticonvulsant or anti-epileptic drug. It is also used to relieve certain types of nerve pain (such as trigeminal neuralgia). This medication works by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity. A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. In 2023, this provider wrote 12 Medicare prescriptions for Carbamazepine, about half the volume of the typical California prescriber of this medication (24). Medicare paid an average of $108.02 per fill, versus $70.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| GalafoldMigalastat Hcl | 11 | $29,457.60 | ≈ Typical |
About Galafold: This medication is used for long-term treatment in people with a certain inherited disease (Fabry disease). Show more ▾ In Fabry disease, a certain enzyme in your body (alpha-galactosidase) does not work the way it should. This leads to a buildup of a certain fatty substance in your kidneys, heart, and other organs. Migalastat works by helping alpha-galactosidase work better so it can remove the fatty substance. Treatment can decrease some symptoms caused by Fabry disease, such as abdominal cramps, diarrhea, burning pain in the hands and feet, heat intolerance, skin rash, kidney/heart disease, or stroke. In 2023, this provider wrote 11 Medicare prescriptions for Galafold, about 85% of the volume of the typical California prescriber of this medication (13). Medicare paid an average of $29,457.60 per fill, versus $29,079.33 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. NICOLA LONGO MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Clinical Genetics (M.D.) prescribing approach at this Los Angeles, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
